Clinical trial
Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)
NCT01988571 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 1, 2014
- Completion date
- September 24, 2020
- Enrollment
- 279 (actual)
- Sites
- 51
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, lymphoma